Saba Capital Management, L.P.Saba Capital Management, L.P.

Institutional investor · Portfolio as of Q1 2025

SEC EDGAR SourceSEC Filings

Top Holdings270 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ECATECAT
Fund

BLACKROCK ESG CAP ALLC TERM

28.6M$451.1M12.2%$11.63+1.65%
2 qtrssince 2024-Q4
Increased
61
BTXBTX
Fund

BLACKROCK TECH AND PRIVATE E

60.7M$379.8M10.3%$6.21-12.72%
2 qtrssince 2024-Q4
Increased
61
BMEZBMEZ
Fund

BLACKROCK HEALTH SCIENCES TE

20.8M$309.2M8.4%$12.03+7.11%
2 qtrssince 2024-Q4
Unchanged
0
PDXPDX
Fund

PIMCO DYNAMIC INCOME STRATEG

7.5M$185.1M5.0%$19.87-4.11%
2 qtrssince 2024-Q4
Increased
66
BCATBCAT
Fund

BLACKROCK CAPITAL ALLOC TR

11.8M$170.1M4.6%$11.67+0.51%
2 qtrssince 2024-Q4
Decreased
0
XGDVXXGDVX
Fund

GABELLI DIVID & INCOME TR

6.3M$153.2M4.1%$27.59-0.80%
2 qtrssince 2024-Q4
Increased
58
ASAASA
Fund

ASA GOLD AND PRECIOUS MTLS L

3.3M$98.1M2.7%$20.07+49.28%
2 qtrssince 2024-Q4
Unchanged
0
NBXGNBXG
Fund

NEUBERGER NEXT GENERATION

7.7M$93.9M2.5%$10.95-1.43%
2 qtrssince 2024-Q4
Increased
57
NFJNFJ
Fund

VIRTUS DIVIDEND INTEREST & P

7.6M$92.6M2.5%$11.50-2.26%
2 qtrssince 2024-Q4
Decreased
0
BSTZBSTZ
Fund

BLACKROCK SCIENCE & TECHNOLO

4.9M$87M2.4%$17.28-11.49%
2 qtrssince 2024-Q4
Decreased
0
ADXADX
Fund

ADAMS DIVERSIFIED EQUITY FD

4.5M$84.8M2.3%$18.23-4.66%
2 qtrssince 2024-Q4
Decreased
0
MEGIMEGI
Fund

NYLI CBRE GBL INFR MEGTRNDS

6.2M$83M2.2%$10.38+11.58%
2 qtrssince 2024-Q4
Increased
55
GAMGAM
Fund

GENERAL AMERN INVS CO INC

1.6M$81.4M2.2%$45.84-0.93%
2 qtrssince 2024-Q4
Increased
56
PEOPEO
Fund

ADAM NAT RES FD INC

2.9M$65.9M1.8%$18.62+7.38%
2 qtrssince 2024-Q4
Increased
46
NQPNQPDelisted
Fund

NUVEEN PA INVT QUALITY MUN F

5.1M$56.8M1.5%$10.08+2.38%
2 qtrssince 2024-Q4
Unchanged
0
AALAAL
PUT

AMERICAN AIRLINES GROUP INC

5.1M$53.4M1.4%
Decreased
BFZBFZDelisted
Fund

BLACKROCK CALIF MUN INCOME T

4.8M$52.2M1.4%$10.40-0.48%
2 qtrssince 2024-Q4
Decreased
0
NXJNXJDelisted
Fund

NUVEEN NJ QLTY MUNI INC

3.8M$44.4M1.2%$10.91-0.09%
2 qtrssince 2024-Q4
Decreased
0
HQLHQL
Fund

ABRDN LIFE SCIENCES INVESTOR

3.2M$40.5M1.1%$11.55+1.39%
2 qtrssince 2024-Q4
Decreased
0
MHIMHIDelisted
Fund

PIONEER MUNICIPAL HIGH INCOM

4.1M$38M1.0%
2 qtrssince 2024-Q4
Increased
46
$3.7B
AUM
270
Positions
Q1 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'25
New5%Increased20%Decreased55%Exited20%
Composition
Equity vs derivatives
Equity99%Puts1%Calls0%
Holding period
Avg <1 quarter
<1Q11%1-4Q89%1-2Y0%2Y+0%

Saba Capital Management, L.P. manages $3.7B across 270 positions as of Q1 2025. Top holdings: ECAT (12.2%), BTX (10.3%), BMEZ (8.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q1 2025 Summary

Active quarter - 28 new positions, 41 exits, 54 increased. Top move: PDX (INCREASED, conviction 66). Portfolio: $3.7B across 270 positions.

Top holdings by portfolio weight

Total AUM$4B
ECAT12.20%
BTX10.27%
BMEZ8.36%
PDX5.00%
BCAT4.60%
XGDVX4.14%
ASA2.65%
NBXG2.54%
NFJ2.50%
BSTZ2.35%
Other2.29%

Portfolio allocation by GICS sector

Sectors10
Unknown92.59%
Financial Services1.79%
Communication Services1.41%
Consumer Cyclical1.34%
Technology1.00%
Industrials0.77%
Real Estate0.42%
Energy0.34%
Healthcare0.25%
Basic Materials0.10%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record47
Conviction33
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GFGFNEW GERMANY FD INC
Q1 2025 Q2 2026+2M shares+$29M
5Q
RMTRMTROYCE MICRO-CAP TR INC COM
Q2 2025 Q2 2026+3.3M shares+$48.6M
4Q
HFROHFROHIGHLAND OPPS & INCOME FD
Q3 2025 Q2 2026+3.7M shares+$30.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used